Plain-English translation of NCT06045156 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Nearly half of patients who receive emergency clot-busting therapy for acute stroke don't recover as well as hoped. This trial tests whether adding —a medication that helps prevent blood clots—within the first 6 hours after that initial stroke treatment can help more patients recover better. Researchers want to see if this additional medication is safe and truly helpful.
Small earlier studies suggest that giving this medication early after stroke clot-busting therapy might improve recovery, but those studies were too small to be sure. This larger trial will provide clearer answers about whether the medication actually works and whether it's safe to use this way.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll receive either or a placebo (an inactive look-alike) as an infusion through an IV line for 24 hours after your initial stroke treatment—starting with a higher dose for 30 minutes, then a lower dose for the remaining time. You'll need to stay in the hospital during this period for monitoring and follow-up visits. The study involves about 1,084 patients across multiple hospitals, and researchers will track your recovery and any side effects over time.
AI-generated summary from trial data · Jul 22, 2026 · Not medical advice
China
Sponsor
The First Hospital of Jilin University
Enrollment target
~1,084 participants
Started
April 2024
Primary completion
January 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.